Providence Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History

Providence Wealth Advisors, LLC

$134 Million
Q3 2024

A detailed history of Providence Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Providence Wealth Advisors, LLC holds 30,817 shares of BMY stock, worth $1.79 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares

30,817

Previous 30,054 2.54%

Holding current value

$1.79 Million

Previous $1.25 Million 27.72%

% of portfolio

1.19%

Previous 1.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $30,260 - $39,485	763 Added 2.54%	30,817 $1.59 Million
Q2 2024 Aug 08, 2024	BUY	$40.25 - $52.99 $22,218 - $29,250	552 Added 1.87%	30,054 $1.25 Million
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $114,432 - $129,744	2,385 Added 8.8%	29,502 $1.6 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $11,809 - $13,204	204 Added 0.76%	27,117 $1.57 Million
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $80,656 - $89,556	-1,266 Reduced 4.49%	26,913 $1.72 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $10,053 - $11,403	153 Added 0.55%	28,179 $1.95 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $5,478 - $6,487	80 Added 0.29%	28,026 $2.02 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $11 - $6,915	-90 Reduced 0.32%	27,946 $2.26 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $71,821 - $79,100	989 Added 3.66%	28,036 $2.13 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $8,545 - $10,247	139 Added 0.52%	27,047 $2 Million
Q4 2021 Jan 12, 2022	BUY	$53.63 - $62.52 $41,724 - $48,640	778 Added 2.98%	26,908 $1.74 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $46,211 - $54,131	-781 Reduced 2.9%	26,130 $1.55 Million
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $13,682 - $14,899	-221 Reduced 0.81%	26,911 $1.79 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $41,063 - $46,184	692 Added 2.62%	27,132 $1.71 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $14,896 - $16,880	258 Added 0.99%	26,440 $1.64 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $184,522 - $204,475	-3,213 Reduced 10.93%	26,182 $1.58 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $11,073 - $12,946	202 Added 0.69%	29,395 $1.73 Million
Q1 2020 May 05, 2020	BUY	$46.4 - $67.43 $7,377 - $10,721	159 Added 0.55%	29,193 $1.61 Million
Q4 2019 Jan 29, 2020	SELL	$49.21 - $64.19 $26,474 - $34,534	-538 Reduced 1.82%	29,034 $1.86 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $45,849 - $54,361	1,072 Added 3.76%	29,572 $1.5 Million
Q2 2019 Jul 22, 2019	BUY	$44.62 - $49.34 $27,307 - $30,196	612 Added 2.19%	28,500 $1.32 Million
Q1 2019 Apr 18, 2019	BUY	$45.12 - $53.8 $64,837 - $77,310	1,437 Added 5.43%	27,888 $1.34 Million
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $4,583 - $5,943	-94 Reduced 0.35%	26,451 $1.35 Million
Q3 2018 Nov 01, 2018	SELL	$55.19 - $62.25 $11,038 - $12,450	-200 Reduced 0.75%	26,545 $1.65 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $1,566 - $1,952	-31 Reduced 0.12%	26,745 $1.48 Million
Q1 2018 Aug 14, 2018	BUY	$59.92 - $68.98 $1.6 Million - $1.85 Million	26,776 New	26,776 $1.66 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Wealth Advisors, LLC with notifications on news.

Account

Providence Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History